Bio ProtocolBIO

A decentralized-science platform where online communities fund biotech research and tokenize its intellectual property.

Rank #477Since January 2025

Price on 31 Oct 2026

C$0.0301 -7.0% since 31 Jul 2026 · 97.6% below its all-time high

The short version

Bio Protocol funds biotech research through BioDAOs, online communities that raise money in protocol auctions and turn research results into tradable IP tokens; BIO stakers curate new BioDAOs and vote on funding. It was founded by Paul Kohlhaas and is tied to Molecule. Most trading is in Korea: Chainalysis counted US$2B of Korean-won BIO volume in the 12 months to June 2026. On 31 Oct 2026 one BIO cost C$0.0301. From 31 Jul 2026 to 31 Oct 2026 its price changed -7.0% in Canadian dollars, and it was 97.6% below its all-time high of C$1.28 set on 3 Jan 2025.^[1]

Checked 31 Oct 2026 · 13 sources · next update about 1 Dec 2026

Price, past year

Past year: high C$0.1226 (3 Nov 2025) · low C$0.0224 (30 Mar 2026) · -74.1%^[1]

Month-end prices (table)

Date	C$	US$
31 Oct 2026	C$0.0302	US$0.0216
30 Sep 2026	C$0.0439	US$0.0309
31 Aug 2026	C$0.0362	US$0.0261
31 Jul 2026	C$0.0319	US$0.0227
30 Jun 2026	C$0.0398	US$0.0280
31 May 2026	C$0.0421	US$0.0305
30 Apr 2026	C$0.0459	US$0.0338
31 Mar 2026	C$0.0230	US$0.0165
28 Feb 2026	C$0.0306	US$0.0224
31 Jan 2026	C$0.0516	US$0.0383
31 Dec 2025	C$0.0602	US$0.0440
30 Nov 2025	C$0.0819	US$0.0584

Daily prices from CoinGecko; C$ converted at the Bank of Canada daily rate. The latest point is live when available. Past prices, not a forecast.

Choose what to see

Key facts

Price, 31 Oct 2026: C$0.0301^[1]
3-month change: -7.0% in C$ (31 Jul 2026 to 31 Oct 2026)^[1]
From its high: 97.6% below its high of C$1.28 (3 Jan 2025)^[1]
Market rank: #477, market value about C$64.6M^[1]
Kind: Token · Ethereum (ERC-20); also on Base, BNB Chain and Solana
Started: January 2025

Checks: the same 9 questions for every coin

Facts, not a rating

Can an admin key create new coins?YesA 5-of-11 multisig and a bridge contract hold the minter role; no cap in code^{[2, 3, 4]}

Can anyone freeze or take coins from holders?NoNo blacklist or admin burn; GoPlus finds no balance-change control^{[5, 4]}

Can the token's contract code be changed?NoFixed contract code on Ethereum, not a proxy^[5]

Is the supply capped?NoNo cap in the contract code; minters can create more^[4]

Any scheduled unlocks in the next 12 months?YesAbout 273M BIO, roughly 13% of circulating^[6]

Does a team or foundation hold over 10% of supply?YesUnvested contributor, investor, advisor and Molecule tokens equal about 20% of supply^[6]

Do network fees reach coin holders?Not disclosedNo fee or revenue figures published; stakers earn BioXP points^{[7, 8]}

Main network hacked or halted in the past 2 years?NoNo Bio Protocol entry in DefiLlama's hacks list^[9]

Is a regulator or court case targeting the coin itself?NoNo live regulator or court case found^[10]

Each answer is a fact with a source, not a score. What each check means.

Who controls it

Founders: Paul Kohlhaas (founder and CEO), Clemens Ortlepp and James Sinka^[11]
Backers: Maelstrom led; Binance Labs, 1kx, Mechanism, Animoca and Northpond joined; US$36.8M raised in 2024-2025^[6]
Admin key: A 5-of-11 multisig and a Wormhole bridge contract hold the minter role; the contract has no supply cap^{[2, 3]}

Supply

In circulation: 2.15B BIO of a 3.32B maximum (64.6%)^[1]
Fully diluted value: 1.55 times its current market value^[1]
Allocation: Early contributors 21.2%, early backers 13.6%, Molecule 10%, advisors 4.2%, community auction 20%, ecosystem 25%^[6]
Unlocks: About 273M BIO (about 13% of circulating) vest in the next 12 months^[6]
Vesting ends: Investors on 27 May 2028; core contributors and advisors on 28 May 2030^[6]

Use and fees

Main use: Staking to curate BioDAOs and vote on treasury funding; BioXP points give access to sales^[7]
Activity: Protocol TVL US$2.8M; BioDAOs have raised over US$33M in total^{[8, 10]}
Revenue: No revenue figure published^[8]

Trading

Daily trading: About C$16.9M a day on average, 31 Jul 2026 to 31 Oct 2026^[1]
Daily turnover: Typically 17.22% of its market value changes hands each day^[1]
20-week average: 21.0% below its 20-week average price^[1]
1-year change: -74.1% in C$^[1]^[12]

History

Not a forecast

Coins ranked 201-500 at this point in past cycles (12-14 months after a Bitcoin peak), one year later: 8,067 cases, 1,187 coins

33% were higher a year later^[13]

Typical result: Median -38% after a year; 33% higher after two years
Lost half or more: 44% within a year
Against Bitcoin: 11% did better than Bitcoin over the year

History, not a forecast.

Red flags and things to watch

2 red flags found

Red flag: A 5-of-11 multisig and a Wormhole bridge contract hold the minter role on the Ethereum BIO contract, which has no supply cap in its code (checked 1 Nov 2026).^{[2, 3, 4]}
Red flag: About 273M BIO, roughly 13% of circulating supply, is scheduled to unlock in the 12 months to Oct 2027.^[6]

OpenLabs, a platform for community-voted research funding, launched on 20 Jun 2026.^[10]
South Korea plans a 22% tax on crypto gains from 2027; Korean-won trading is BIO's largest market (Chainalysis, 5 Oct 2026).^[10]

Checked: admin keys, contract upgrades, unlocks, insider supply, hacks, legal actions and claims against records.

Sources and dates

Facts as of 31 Oct 2026. Prices from CoinGecko in Canadian and US dollars; US$ figures without a C$ price are converted at 1.3976 C$ per US$.